Cris Frangold
View Cris Frangold's Articles BY TICKER:
AAPL,
ABT,
ABX,
ADBE,
AGNC,
AMZN,
APA,
APC,
ARR,
ATPG,
AXP,
AZN,
BAC,
BBRY,
BHP,
BIDU,
BMY,
BP,
C,
CFTMF.PK,
CHK,
CHL,
CIM,
CMG,
CMO,
COF,
COG,
COP,
CSCO,
CTL,
CVX,
CYS,
DFS,
DVN,
DX,
EMC,
EOG,
ESRX,
F,
FB,
FCX,
FSLR,
FTR,
GE,
GG,
GM,
GOOG,
GSK,
HPQ,
HTS,
IDIX,
INO,
INTC,
JNJ,
JPM,
KO,
KOG,
LLY,
LMCA,
LNVGY.PK,
LPTN,
LULU,
MCD,
MO,
MRK,
MRO,
MSFT,
MU,
MYL,
NBL,
NEM,
NFLX,
NFX,
NLY,
NOK,
NVS,
ONCS.OB,
ONVO.PK,
ORCL,
OXY,
P,
PFE,
PMT,
RIO,
S,
SD,
SIRI,
SLW,
SPPI,
SSNLF.PK,
T,
USB,
VALE,
VLO,
VRTX,
VRX,
VVUS,
VZ,
WFC,
WIN,
WM,
WMT,
XOM,
YHOO
- Idenix: New HCV Drug Could Be A Blockbuster
- Armour: This 17% Yielder Is A Buy Now
- Chevron: Profit From These New Ventures Now
-
Silver Wheaton: The Best Buy In Mining
-
Kodiak: Ignore The Volatility, Buy Now
- EOG: Buy This Undervalued Stock Now
- New Headwinds Facing Google
- HP: A $33 Stock After The Turnaround?
- U.S. Bancorp: Don't Ignore This Lucrative Stock
- ATP Ready To Leap On $68 Million Lawsuit
- Johnson & Johnson Shares Positioned To Leap Higher
- Cisco A Hot Buy On New Product Line
- Wells Fargo: The Stock To Own For A Housing Recovery
- ComScore Study Enough To Push Facebook Higher?
- 7 Solar Stocks Now Moving On A Sector Shakedown
- How Will Zoetis Spinoff Impact Pfizer Stock?
-
Frontier Could Plunge If New Assets Underperform
- Merck: Can 5 New Drugs Fill Singulair Gap?
- How To Play Exxon For A 20% Gain By 2013
- Marathon A Steal At $25
- Apache: Buy This Stable Oil And Gas Stock Now
- 5 Hot Silver Plays To Consider Now
- EMC: Deeply Undervalued, Ready To Surge
- Google Ready To Jump Higher On Mobile Growth
- Chevron Has 23% Upside Potential Now
- Anadarko Ready For A Massive Rally
- Intel Stock Ready For Growth In 2013
- Restructure Will Spark Confidence In Chesapeake
- Avoid Freeport; Buy Barrick, Billiton Instead
- Ride Wal-Mart $4 Higher By 2013
- Don't Believe Wall Street, Buy JPMorgan Chase
- Why Investors Are Dumping ATP Now